Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Sudden breathlessness, followed by death; not feeling well/malaise; Fever: 38 to 40.5 degrees Celsius; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB regulatory authority NL-LRB-00497586. A 75-years-old female patient received BNT162B2 (COMIRNATY), first dose via an unspecified route of administration on 01Apr2021 (Lot Number: ET3674) as single dose for COVID-19 immunisation. Medical history included COVID-19 from 28Dec2020 without disease symptoms and cardiovascular disease. Concomitant medication(s) included haloperidol and clopidogrel. On 04Apr2021, the patient experienced sudden shortness of breath and not feeling well/malaise, after which death. Adverse event came about suddenly. The patient also experienced fever: 38 to 40.5 degrees Celsius on 04Apr2021. There were no diagnostic procedures. The patient underwent SARS-COV-2 test positive on 28Dec2020. The patient died on an unspecified date. It was not reported if an autopsy was performed. The event outcome for events was fatal. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Sudden breathlessness, followed by death; Malaise; Fever: 38 to 40.5 degrees Celsius
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166